Both in Pharmaceuticals
Merck & Co. vs Pfizer
Over the past year MRK returned +81.3% and PFE returned +23.8%; their daily moves had a correlation of 0.46.
MRK +81.3% PFE +23.8%Growth of $1, one year, split-adjusted
| Metric | MRK | PFE |
|---|---|---|
| Price | $149.52 | $30.52 |
| Market cap | $368.89B | $173.95B |
| Today | +2.18% | +1.90% |
| 1 month | +4.0% | +8.5% |
| 6 months | +33.3% | +15.9% |
| Year to date | +42.0% | +22.6% |
| 1 year | +72.7% | +25.6% |
| Revenue growth (YoY) | +5.1% | +2.6% |
| Gross margin | 73.5% | 72.8% |
| Net margin | −8.0% | −1.6% |
| P/E (TTM) | 116.3× | 40.2× |
| Price / sales | 5.5× | 2.7× |
| Net cash | -$46.77B | -$51.49B |
| Dividend yield | 2.27% | 5.64% |
| Volatility (60d) | 36.0% | 19.8% |
| Short % of float | 1.1% | 2.4% |
| Next earnings | — | Nov 3, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).